Company Overview - KabaFusion is a leading U.S. provider of essential chronic and acute infusion therapies, serving patients in 45 states through a nationwide network of home infusion pharmacies, ambulatory infusion sites, and home health agencies [2][5] - Founded in 2010 by Dr. Sohail Masood, KabaFusion focuses on patient-centered care and has over 30 years of clinical experience in infusion therapies [5] Investment and Growth - Novo Holdings has signed a definitive agreement to exit its investment in KabaFusion, which is subject to customary closing conditions [1] - Since partnering with Novo Holdings in November 2022, KabaFusion has significantly expanded its geographic footprint, enhanced its ambulatory infusion capabilities, and broadened its therapeutic offerings, nearly doubling in size [3][4] - The partnership with Novo Holdings has been instrumental in KabaFusion's growth trajectory and expansion initiatives, aiming to provide convenient and cost-effective therapy access to a broader array of patients [4] Future Directions - KabaFusion is entering a new chapter with a new partner, Nautic Partners, while continuing its commitment to delivering excellent patient care [4] - The company aims to maintain its patient-first mission and leverage its new partnership for further growth [4]